37662-3126 NDC - ZIRCONIUM OXYDATUM

Drug Information

  • Product NDC: 37662-3126
  • Proprietary Name: Zirconium Oxydatum
  • Non Proprietary Name: Zirconium Oxydatum
  • Active Ingredient(s): 30 [hp_C]/1 ZIRCONIUM OXIDE
  • Administration Route(s): ORAL
  • Dosage Form(s): PELLET

Labeler Information

Field Name Field Value
Labeler Name: Hahnemann Laboratories, INC.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:5/4/2023

Package Information

No. Package Code Package Description Billing Unit
137662-3126-180 PELLET in 1 VIAL, GLASS (37662-3126-1)
237662-3126-2200 PELLET in 1 VIAL, GLASS (37662-3126-2)
337662-3126-31200 PELLET in 1 BOTTLE, GLASS (37662-3126-3)
437662-3126-44000 PELLET in 1 BOTTLE, GLASS (37662-3126-4)

NDC Record

Field Name Field Value Definition
PRODUCT NDC37662-3126The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEZirconium OxydatumThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEZirconium OxydatumThis is the date that the labeler indicates was the start of its marketing of the drug product.
DOSAGE FORM NAMEPELLETThis is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE5/4/2023This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICName of Company corresponding to the labeler code segment of the Product NDC.
LABELER NAMEHahnemann Laboratories, INC.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEZIRCONIUM OXIDEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH30 
ACTIVE INGRED UNIT[hp_C]/1 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 12/6/2025